185 research outputs found
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
Several studies described an association between killer-cell immunoglobulin-like
receptor (KIR)/HLA gene combinations and clinical outcomes in various diseases. In
particular, an important combined role for KIR3DS1 and HLA-B Bw4-I80 in controlling
viral infections and a higher protection against leukemic relapses in donor equipped
with activating KIRs in haplo-HSCT has been described. Here, we show that KIR3DS1
mediates positive signals upon recognition of HLA-B*51 (Bw4-I80) surface molecules
on target cells and that this activation occurs only in Bw4-I80neg individuals, including
those carrying particular KIR/HLA combination settings. In addition, killing of HLA-B*51
transfected target cells mediated by KIR3DS1+/NKG2A+ natural killer (NK) cell clones
from Bw4-I80neg donors could be partially inhibited by antibody-mediated masking of
KIR3DS1. Interestingly, KIR3DS1-mediated recognition of HLA-B*51 could be better
appreciated under experimental conditions in which the function of NKG2D was reduced
by mAb-mediated blocking. This experimental approach may mimic the compromised
function of NKG2D occurring in certain viral infections. We also show that, in KIR3DS1+/
NKG2A+ NK cell clones derived from an HLA-B Bw4-T80 donor carrying 2 KIR3DS1
gene copy numbers, the positive signal generated by the engagement of KIR3DS1
by HLA-B*51 resulted in a more efficient killing of HLA-B*51-transfected target cells.
Moreover, in these clones, a direct correlation between KIR3DS1 and NKG2D surface
density was detected, while the expression of NKp46 was inversely correlated with
that of KIR3DS1. Finally, we analyzed KIR3DS1+/NKG2A+ NK cell clones from a HLA-B
Bw4neg donor carrying cytoplasmic KIR3DL1. Although these clones expressed lower
levels of surface KIR3DS1, they displayed responses comparable to those of NK cell
clones derived from HLA-B Bw4neg donors that expressed surface KIR3DL1. Altogether
these data suggest that, in particular KIR/HLA combinations, KIR3DS1 may play a role
in the process of human NK cell educatio
Identification of Placenta Growth Factor Determinants for Binding and Activation of Flt-1 Receptor
n/
KIR3DS1-mediated recognition of HLA-*B51: modulation of KIR3DS1 responsiveness by self HLA-B allotypes and effect on NK cell licensing
Several studies described an association between killer-cell immunoglobulin-like receptor (KIR)/HLA gene combinations and clinical outcomes in various diseases [1-2]. Here, we show that KIR3DS1 mediates positive signals upon recognition of HLA-B*51 (Bw4-I80) surface molecules on target cells and that this activation occurs only in Bw4-I80neg individuals, including those carrying particular KIR/HLA combination settings. In addition, killing of HLA-B*51 transfected target cells mediated by KIR3DS1+/NKG2A+ NK cell clones from Bw4-I80neg donors could be partially inhibited by antibody-mediated masking of KIR3DS1. Interestingly, KIR3DS1-mediated recognition of HLA-B*51 could be better appreciated under experimental conditions in which the function of NKG2D was reduced by mAb-mediated blocking. This experimental approach may mimic the compromised function of NKG2D occurring in certain viral infections. We also show that, in KIR3DS1+/NKG2A+ NK cell clones derived from an HLA-B Bw4-T80 donor carrying 2 KIR3DS1 gene copy numbers, the positive signal generated by the engagement of KIR3DS1 by HLA-B*51 resulted in a more efficient killing of HLA-B*51-transfected target cells. Finally, we analyzed KIR3DS1+/NKG2A+ NK cell clones from a HLA-B Bw4neg donor carrying cytoplasmic KIR3DL1. Although these clones expressed lower levels of surface KIR3DS1, they displayed responses comparable to those of NK cell clones derived from HLA-B Bw4neg donors that expressed surface KIR3DL1. Altogether these data suggest that, in particular KIR/HLA combinations, KIR3DS1 may play a role in the process of human NK cell education
The inhibition of caspase-1- does not revert particulate matter (PM)-induced lung immunesuppression in mice
Evaluation of Endometrial Urocortin Secretion for Prediction of Pregnancy after Intrauterine Insemination
Abstract
Background: Urocortin is a neuropeptide produced by the human endometrium and has biological effects putatively important for promoting blastocyst implantation. We measured urocortin concentrations in samples of endometrial wash fluid collected from women with unexplained infertility who underwent intrauterine insemination (IUI).
Methods: Patients 28–42 years of age (n = 71) were consecutively enrolled after a complete clinical evaluation. Endometrial wash fluid was retrieved before IUI, at the time of ultrasound evaluation of endometrial thickness. Urocortin concentrations were assayed with a specific ELISA.
Results: After IUI, 28 patients (39%) became pregnant. Urocortin concentrations were significantly higher in women who became pregnant than in those who did not (0.38 μg/L vs 0.13 μg/L, P <0.0001). At a cutoff of 0.321 μg/L, urocortin results were positive in 61% [95% confidence interval (CI), 41%–78%] of women who had successful implantation and negative in 98% (95% CI, 88%–99.6%) of those who did not. The pregnancy rate for women with urocortin concentrations >0.32 μg/L was 94%, which differed significantly (P <0.05) from the overall pregnancy rate of 39% in the study population.
Conclusions: Urocortin is measurable in endometrial wash fluid, and its concentrations before IUI are higher in women who subsequently achieve pregnancy. These data suggest that the probability of having a successful pregnancy-producing IUI may be better estimated by measuring urocortin in endometrial wash fluid
Uptake of CCR7 by KIR2DS4+ NK cells is induced upon recognition of certain HLA-C alleles: implication of activating KIRs in haploidentical HSCT
Alloreactive NK cells have been shown to play a crucial role in the successful therapy of high risk acute leukemias in the haplo-HSCT setting (1-4). Recently, we have shown that in KIR/KIR-ligand mismatched haplo-HCT a remarkable advantage may exist in selecting KIR2DS1+ donors to be used in C2+ recipients, not only for their killing capability against recipient’s leukemic cells, but also for their ability of killing allogeneic DC and T cell blasts, thus preventing GvHD and graft rejection. Moreover we have shown that, as previously described for KIR2DS1, also KIR2DS4, another activating KIR, may induce acquisition of CCR7 and migratory properties by human NK cells interacting with B-EBV infected cells expressing spe- cific HLA molecules. Importantly, this de novo CCR7 expression, occurring by a mech- anism of trogocytosis, may represent a mechanism by which alloreactive KIR2DS1+ or KIR2DS4+ NK cells can migrate to lymph nodes, kill recipient’s DCs and prevent priming of alloreactive donor’s T cells as well as induction of graft-versus-host dis- ease (GvHD)
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
BACKGROUND: Despite Natural Killer (NK) cells were originally defined as effectors of spontaneous cytotoxicity against tumors, extremely limited information is so far available in humans on their capability of killing cancer cells in an autologous setting. METHODOLOGY/PRINCIPAL FINDINGS: We have established a series of primary melanoma cell lines from surgically resected specimens and here showed that human melanoma cells were highly susceptible to lysis by activated autologous NK cells. A variety of NK cell activating receptors were involved in killing: particularly, DNAM-1 and NKp46 were the most frequently involved. Since self HLA class I molecules normally play a protective role from NK cell-mediated attack, we analyzed HLA class I expression on melanomas in comparison to autologous lymphocytes. We found that melanoma cells presented specific allelic losses in 50% of the patients analyzed. In addition, CD107a degranulation assays applied to NK cells expressing a single inhibitory receptor, revealed that, even when expressed, specific HLA class I molecules are present on melanoma cell surface in amount often insufficient to inhibit NK cell cytotoxicity. Remarkably, upon activation, also the so called "unlicensed" NK cells, i.e. NK cells not expressing inhibitory receptor specific for self HLA class I molecules, acquired the capability of efficiently killing autologous melanoma cells, thus additionally contributing to the lysis by a mechanism independent of HLA class I expression on melanoma cells. CONCLUSIONS/SIGNIFICANCE: We have investigated in details the mechanisms controlling the recognition and lysis of melanoma cells by autologous NK cells. In these autologous settings, we demonstrated an efficient in vitro killing upon NK cell activation by mechanisms that may be related or not to abnormalities of HLA class I expression on melanoma cells. These findings should be taken into account in the design of novel immunotherapy approaches against melanoma
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity characterized by the unique ability of killing tumor and virally infected cells without any prior priming and expansion of specific clones. The \u201cmissing-self\u201d theory, proposed by Klas Karre, the seminal discovery of the first prototypic HLA class I-specific inhibitory receptors, and, later, of the Natural Cytotoxicity Receptors (NCRs) by Alessandro Moretta, provided the bases to understand the puzzling behavior of NK cells. Actually, those discoveries proved crucial also for many of the achievements that, along the years, have contributed to the modern view of these cells. Indeed, NK cells, besides killing susceptible targets, are now known to functionally interact with different immune cells, sense pathogens using TLR, adapt their responses to the local environment, and, even, mount a sort of immunological memory. In this review, we will specifically focus on the main activating NK receptors and on their crucial role in the ever-increasing number of functions assigned to NK cells and other innate lymphoid cells (ILCs)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Natural killer (NK) cells contribute to the first line of defense against viruses and to the control of tumor growth and metastasis spread. The discovery of HLA class I specific inhibitory receptors, primarily of killer Ig-like receptors (KIRs), and of activating receptors has been fundamental to unravel NK cell function and the molecular mechanisms of tumor cell killing. Stemmed from the seminal discoveries in early '90s, in which Alessandro Moretta was the major actor, an extraordinary amount of research on KIR specificity, genetics, polymorphism, and repertoire has followed. These basic notions on NK cells and their receptors have been successfully translated to clinical applications, primarily to the haploidentical hematopoietic stem cell transplantation to cure otherwise fatal leukemia in patients with no HLA compatible donors. The finding that NK cells may express the PD-1 inhibitory checkpoint, particularly in cancer patients, may allow understanding how anti-PD-1 therapy could function also in case of HLA class Ineg tumors, usually susceptible to NK-mediated killing. This, together with the synergy of therapeutic anti-checkpoint monoclonal antibodies, including those directed against NKG2A or KIRs, emerging in recent or ongoing studies, opened new solid perspectives in cancer therapy
- …